Insiders iNtRON Biotechnology, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-27 EDT			5-day change	1st Jan Change
5,990 ^KRW	-0.17%		-6.26%	-31.78%

03-13	INtRON Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-15	Intron Biotechnology, Inc. Announces New Drug Part Secures A Potent Anti-Cancer Candidate, PHAGERIA®, with Broad Antimicrobial Activity Against ETBF (Enterotoxigenic B. Fragilis), A Harmful Microbe Associated with Colorectal Cancer	CI

No results for this search